EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.8.5.4 | Heart Failure |
34132787 |
Discovery of a first-in-class inhibitor of sulfide:quinone oxidoreductase that protects against adverse cardiac remodeling and heart failure. |
causal interaction therapeutic application unassigned |
3 4 0 |
1.8.5.4 | Leigh Disease |
32160317 |
Pathogenic variants in SQOR encoding sulfide:quinone oxidoreductase are a potentially treatable cause of Leigh disease. |
causal interaction diagnostic usage therapeutic application unassigned |
1 3 1 0 |
1.8.5.4 | Metabolic Syndrome |
20332082 |
Lipogenesis is decreased by grape seed proanthocyanidins according to liver proteomics of rats fed a high fat diet. |
causal interaction therapeutic application unassigned |
3 4 0 |
1.8.5.4 | Osteoporosis |
26258864 |
Association of the I264T variant in the sulfide quinone reductase-like (SQRDL) gene with osteoporosis in Korean postmenopausal women. |
causal interaction ongoing research therapeutic application unassigned |
4 4 2 0 |
1.8.5.4 | Osteoporosis |
29855663 |
Genetic susceptibility of postmenopausal osteoporosis on sulfide quinone reductase-like gene. |
causal interaction ongoing research unassigned |
4 4 0 |
1.8.5.4 | Osteoporosis, Postmenopausal |
26258864 |
Association of the I264T variant in the sulfide quinone reductase-like (SQRDL) gene with osteoporosis in Korean postmenopausal women. |
causal interaction ongoing research therapeutic application unassigned |
4 4 2 0 |
1.8.5.4 | Osteoporosis, Postmenopausal |
29855663 |
Genetic susceptibility of postmenopausal osteoporosis on sulfide quinone reductase-like gene. |
causal interaction ongoing research unassigned |
4 4 0 |